Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
With a market cap of 1.1T, Eli Lilly(LLY) trades at $1,169.66. The stock has a price-to-earnings ratio of 40.39 and currently yields dividends of 0.56%.
During the trading session on 2026-10-09, Eli Lilly(LLY) shares reached a daily high of $1,169.98 and a low of $1,166.42. At a current price of $1,169.66, the stock is +0.3% higher than the low and still -0.0% under the high.
Trading activity shows a volume of 7.25K, compared to an average daily volume of 2.27M.
The stock's 52-week range extends from a low of $783.85 to a high of $1,292.65.
The stock's 52-week range extends from a low of $783.85 to a high of $1,292.65.
LLY News
Investing Cantor Fitzgerald Lifts Price Targets on Four Pharma Giants Amid Mixed Growth Outlooks Cantor Fitzgerald just bumped price targets on Eli Lilly, AbbVi...
Eli Lilly (LLY) announced new exploratory data from the TOGETHER-PsO Phase 3b clinical trial evaluating the concomitant use of Taltz and Zepbound compared with...
BofA analyst Jason Gerberry lowered the firm’s price target on Eli Lilly (LLY) to $1,341 from $1,344 and keeps a Buy rating on the shares as part of the firm’s...
Analyst ratings
84%
of 32 ratingsMore LLY News
Bond giant Pimco now sees a real chance of US 10 year Treasury yields hitting 6%, which pulls money toward safer income and makes investors choosier about where...
UBS analyst Michael Yee clearly preferred Eli Lilly (LLY -1.61%) over Novo Nordisk (NVO -0.21%) in a recent discussion with CNBC. Describing Eli Lilly as a grow...
Thursday, October 8, 2026 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research report...
Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. Eli Lilly and Company (LLY) is running a Phase 3 trial called “A Study of Orfo...
Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. Eli Lilly & Co.’s new Phase 1 trial, “A Placebo-Controlled, Single- and Multip...
Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. The study “A Phase 1, Open-Label Study to Evaluate the Effect of Eloralintide...
Eli Lilly (LLY -4.54%) is trying to turn blockbuster obesity drugs into something much bigger. Its path to $1,500 depends on whether new medicines, additional i...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.